|
1
|
Moch H, Humphrey PA, Ulbright T and Reuter
V: WHO Classification of Tumours of the Urinary System and Male
Genital Organs. 4th. IARC; Lyon: 2016
|
|
2
|
Jonasch E, Futreal PA, Davis IJ, Bailey
ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J,
et al: State of the science: An update on renal cell carcinoma. Mol
Cancer Res. 10:859–880. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kaelin WG Jr: The von Hippel-Lindau tumour
suppressor protein: O2 sensing and cancer. Nat Rev Cancer.
8:865–873. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Young AP, Schlisio S, Minamishima YA,
Zhang Q, Li L, Grisanzio C, Signoretti S and Kaelin WG Jr: VHL loss
actuates a HIF-independent senescence programme mediated by Rb and
p400. Nat Cell Biol. 10:361–369. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Macher-Goeppinger S, Bermejo JL,
Schirmacher P, Pahernik S, Hohenfellner M and Roth W:
Senescence-associated protein p400 is a prognostic marker in renal
cell carcinoma. Oncol Rep. 30:2245–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Welford SM, Dorie MJ, Li X, Haase VH and
Giaccia AJ: Renal oxygenation suppresses VHL loss-induced
senescence that is caused by increased sensitivity to oxidative
stress. Mol Cell Biol. 30:4595–4603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Courtois-Cox S, Genther Williams SM,
Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein
PE, MacCollin M and Cichowski K: A negative feedback signaling
network underlies oncogene-induced senescence. Cancer Cell.
10:459–472. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michaloglou C, Vredeveld LC, Soengas MS,
Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi
WJ and Peeper DS: BRAFE600-associated senescence-like cell cycle
arrest of human naevi. Nature. 436:720–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Trotman LC, Shaffer D, Lin HK,
Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al:
Crucial role of p53-dependent cellular senescence in suppression of
Pten-deficient tumorigenesis. Nature. 436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Serrano M, Lin AW, McCurrach ME, Beach D
and Lowe SW: Oncogenic ras provokes premature cell senescence
associated with accumulation of p53 and p16INK4a. Cell. 88:593–602.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimi T, Butin-Israeli V, Adam SA,
Hamanaka RB, Goldman AE, Lucas CA, Shumaker DK, Kosak ST, Chandel
NS and Goldman RD: The role of nuclear lamin B1 in cell
proliferation and senescence. Genes Dev. 25:2579–2593. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jung HJ, Lee JM, Yang SH, Young SG and
Fong LG: Nuclear lamins in the brain-new insights into function and
regulation. Mol Neurobiol. 47:290–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hallstrom TC, Mori S and Nevins JR: An
E2F1-dependent gene expression program that determines the balance
between proliferation and cell death. Cancer Cell. 13:11–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shah PP, Donahue G, Otte GL, Capell BC,
Nelson DM, Cao K, Aggarwala V, Cruickshanks HA, Rai TS, McBryan T,
et al: Lamin B1 depletion in senescent cells triggers large-scale
changes in gene expression and the chromatin landscape. Genes Dev.
27:1787–1799. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Padiath QS, Saigoh K, Schiffmann R,
Asahara H, Yamada T, Koeppen A, Hogan K, Ptácek LJ and Fu YH: Lamin
B1 duplications cause autosomal dominant leukodystrophy. Nat Genet.
38:1114–1123. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moss SF, Krivosheyev V, de Souza A, Chin
K, Gaetz HP, Chaudhary N, Worman HJ and Holt PR: Decreased and
aberrant nuclear lamin expression in gastrointestinal tract
neoplasms. Gut. 45:723–729. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Broers JL, Raymond Y, Rot MK, Kuijpers H,
Wagenaar SS and Ramaekers FC: Nuclear A-type lamins are
differentially expressed in human lung cancer subtypes. Am J
Pathol. 143:211–220. 1993.PubMed/NCBI
|
|
19
|
Coradeghini R, Barboro P, Rubagotti A,
Boccardo F, Parodi S, Carmignani G, D'Arrigo C, Patrone E and Balbi
C: Differential expression of nuclear lamins in normal and
cancerous prostate tissues. Oncol Rep. 15:609–613. 2006.PubMed/NCBI
|
|
20
|
Sun S, Xu MZ, Poon RT, Day PJ and Luk JM:
Circulating Lamin B1 (LMNB1) biomarker detects early stages of
liver cancer in patients. J Proteome Res. 9:70–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Izdebska M, Gagat M and Grzanka A:
Overexpression of lamin B1 induces mitotic catastrophe in colon
cancer LoVo cells and is associated with worse clinical outcomes.
Int J Oncol. 52:89–102. 2018.PubMed/NCBI
|
|
22
|
Li L, Du Y, Kong X, Li Z, Jia Z, Cui J,
Gao J, Wang G and Xie K: Lamin B1 is a novel therapeutic target of
betulinic acid in pancreatic cancer. Clin Cancer Res. 19:4651–4661.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Macher-Goeppinger S, Aulmann S, Tagscherer
KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M,
Sykora J, Walczak H, et al: Prognostic value of tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL) and TRAIL
receptors in renal cell cancer. Clin Cancer Res. 15:650–659. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gringon D, Eble J, Bonsib SM and Moch H:
Pathology and Genetics of Tumors of the Urinary System & Male
Genital Organs. Eble JN, Sauter G, Epstein J and Sesterhenn I:
Clear cell renal cell carcinoma. IARC; Lyon, France: pp. 23–25.
2004
|
|
25
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM Classification of Malignant Tumours. (7th). 2009.
|
|
26
|
Foersch S, Schindeldecker M, Keith M,
Tagscherer KE, Fernandez A, Stenzel PJ, Pahernik S, Hohenfellner M,
Schirmacher P, Roth W and Macher-Goeppinger S: Prognostic relevance
of androgen receptor expression in renal cell carcinomas.
Oncotarget. 8:78545–78555. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shvarts O, Lam JS, Kim HL, Han KR, Figlin
R and Belldegrun A: Eastern Cooperative Oncology Group performance
status predicts bone metastasis in patients presenting with renal
cell carcinoma: Implication for preoperative bone scans. J Urol.
172:867–870. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hertz-Picciotto I and Rockhill B: Validity
and efficiency of approximation methods for tied survival times in
Cox regression. Biometrics. 53:1151–1156. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nagano T, Nakano M, Nakashima A, Onishi K,
Yamao S, Enari M, Kikkawa U and Kamada S: Identification of
cellular senescence-specific genes by comparative transcriptomics.
Sci Rep. 6:317582016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brodaczewska KK, Szczylik C, Fiedorowicz
M, Porta C and Czarnecka AM: Choosing the right cell line for renal
cell cancer research. Mol Cancer. 15:832016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Furge KA, Chen J, Koeman J, Swiatek P,
Dykema K, Lucin K, Kahnoski R, Yang XJ and Bin TT: Detection of DNA
copy number changes and oncogenic signaling abnormalities from gene
expression data reveals MYC activation in high-grade papillary
renal cell carcinoma. Can Res. 67:3171–3176. 2007. View Article : Google Scholar
|
|
33
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choueiri TK and Motzer RJ: Systemic
therapy for metastatic renal-cell carcinoma. N Engl J Med.
376:354–366. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ewald JA, Desotelle JA, Wilding G and
Jarrard DF: Therapy-induced senescence in cancer. J Natl Cancer
Inst. 102:1536–1546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Acosta JC and Gil J: Senescence: A new
weapon for cancer therapy. Trends Cell Biol. 22:211–219. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu Y, Xu L, Zhang J, Hu X, Liu Y, Yin H,
Lv T, Zhang H, Liu L, An H, et al: Sunitinib induces cellular
senescence via p53/Dec1 activation in renal cell carcinoma cells.
Cancer Sci. 104:1052–1061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Park CW, Bak Y, Kim MJ, Srinivasrao G,
Hwang J, Sung NK, Kim BY, Yu JH, Hong JT and Yoon DY: The novel
small molecule STK899704 promotes senescence of the human A549
NSCLC cells by inducing DNA damage responses and cell cycle arrest.
Front Pharmacol. 9:1632018. View Article : Google Scholar : PubMed/NCBI
|
